0 views 0 likes

Amr Moursi

neurosurgery · View profile →

Our novel glioblastoma microfluidic platform

Video Published 2026-07-29 Updated 2026-07-29

Topic Overview

This video demonstrates a novel microfluidic platform that maintains viable human glioblastoma tissue ex vivo for up to 12 days, enabling therapeutic drug testing in a brain-mimetic environment. The system bridges the gap between traditional cell culture and animal models for neuro-oncology research.

Key Takeaways

  • Novel microfluidic platform maintains viable human glioblastoma tissue ex vivo for up to 12 days
  • Platform enables drug testing in a physiologically relevant brain microenvironment model
  • Technology allows real-time observation of therapeutic responses in patient-derived GBM tissue
  • Collaborative research tool bridges gap between 2D cell culture and animal models for neuro-oncology research

Keywords

Glioblastoma Microfluidics Ex Vivo Tissue Culture Drug Testing Platform Neuro-oncology Translational Research

Hashtags

#Glioblastoma #Microfluidics #NeuroOncology #TranslationalResearch

Comments

Loading comments…